心室辅助装置对儿童心脏移植结局的影响:ACTION与PHTS数据库关联队列分析
该研究关联ACTION与PHTS数据库,比较移植前接受VAD支持(VG,n=405)与仅药物治疗(MG,n=955)的18岁以下心脏移植患者移植后结局。倾向性匹配后VAD与移植丢失无关;未匹配多因素分析中,PC和PP装置、CHD、机械通气等与移植丢失独立相关,VG与移植后感染风险降低相关。
要点
- 倾向性匹配后,移植前VAD支持与心脏移植后移植丢失无关。
- 未匹配分析中,PC和PP装置、CHD、机械通气等与移植丢失独立相关。
- VAD组移植后感染风险较低(HR 0.75,95%CI 0.56-0.99)。
核心结论
- 倾向性匹配后,VAD支持与儿童心脏移植后移植丢失无关。
- 未匹配分析中装置类型差异可能反映患者复杂性而非装置特异性效应。
研究设计与样本
- ACTION与PHTS数据库关联的回顾性队列研究,纳入2018年4月1日至2022年6月30日期间列出的18岁以下心脏移植患者。
- 共纳入1360例患者,其中VAD组405例,药物治疗组955例。
- 采用Kaplan-Meier分析、log-rank检验和Cox比例风险模型分析移植后移植丢失,并进行倾向性匹配。
主要发现
- 移植时VAD组年龄更小(4.2 [0.8-13.3] vs 7.3 [0.9-14.0]岁;p=0.03)。
- VAD组移植时接受机械通气的比例更高(15.1% vs 11.0%;p=0.03)。
- 药物治疗组先天性心脏病比例高于VAD组(64.8% vs 35.1%;p<0.0001)。
- 总体移植生存率在VAD组与药物治疗组间无差异(p=0.17)。
- 未匹配多因素分析中,PC和PP装置、CHD、Black或Other种族、移植时机械通气及未使用诱导治疗与移植丢失独立相关(均p<0.05);VAD与移植后感染风险降低相关(HR 0.75 [95% CI 0.56-0.99])。
临床怎么用
- 儿童心脏移植前VAD支持不增加倾向性匹配后的移植丢失风险。
- 需关注VAD相关主要不良事件(感染、出血、呼吸衰竭)与移植后不良结局的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pediatric ventricular assist devices (VAD) improve waitlist mortality. We aimed to compare outcomes after heart transplant (HT) based on pre-HT support in patients <18 years at listing. METHODS: VAD and post-HT data were linked between ACTION and PHTS databases, respectively (4/1/2018-6/30/2022). Support groups were defined as medical (MG) and VAD (VG). Within VG, device groups were defined as paracorporeal pulsatile (PP), paracorporeal continuous (PC), and implantable continuous (IC). Kaplan-Meier analysis, the log-rank test, and Cox proportional hazards modeling analyzed graft loss post-HT, with and without propensity matching. RESULTS: The 1,360 patients included VG = 405 and MG = 955. At HT, VG was younger (4.2 [0.8-13.3] vs 7.3 [0.9-14.0] years; p = 0.03) and more likely to receive mechanical ventilation (15.1% vs 11.0%; p = 0.03). The proportion of congenital heart disease (CHD) was higher in MG (64.8%) vs VG (35.1%; p < 0.0001). Overall graft survival did not differ between VG and MG (p = 0.17). In unmatched multivariable analysis, PC and PP devices, CHD, Black or Other race, mechanical ventilation at transplant, and absence of induction therapy were independently associated with graft loss (all p < 0.05), while VG was associated with lower risk of post-HT infection (HR 0.75 [95% CI 0.56-0.99]). In propensity-matched cohorts, VAD was not associated with graft loss. Within VG, VAD major adverse events of infection, bleeding, and respiratory failure were associated with inferior post-HT outcomes. CONCLUSION: VAD support was not associated with graft loss after propensity matching. Differences by device type in unmatched analyses likely reflect differences in patient complexity rather than device-specific effects.
引用
- Auerbach SR, Anton K, Bansal N, et al. Impact of ventricular assist device use on pediatric heart transplant outcomes in a linked cohort of the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) and Pediatric Heart Transplant Society (PHTS) databases. J Heart Lung Transplant. 2026. PMID: 42826812. doi:10.1016/j.healun.2026.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。